1. Home
  2. ELEV vs AHT Comparison

ELEV vs AHT Comparison

Compare ELEV & AHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELEV
  • AHT
  • Stock Information
  • Founded
  • ELEV 2019
  • AHT 2003
  • Country
  • ELEV United States
  • AHT United States
  • Employees
  • ELEV N/A
  • AHT N/A
  • Industry
  • ELEV Biotechnology: Pharmaceutical Preparations
  • AHT Real Estate Investment Trusts
  • Sector
  • ELEV Health Care
  • AHT Real Estate
  • Exchange
  • ELEV Nasdaq
  • AHT Nasdaq
  • Market Cap
  • ELEV 37.6M
  • AHT 40.8M
  • IPO Year
  • ELEV 2021
  • AHT 2003
  • Fundamental
  • Price
  • ELEV $0.26
  • AHT $7.41
  • Analyst Decision
  • ELEV Buy
  • AHT
  • Analyst Count
  • ELEV 7
  • AHT 0
  • Target Price
  • ELEV $3.78
  • AHT N/A
  • AVG Volume (30 Days)
  • ELEV 2.1M
  • AHT 21.4K
  • Earning Date
  • ELEV 03-06-2025
  • AHT 05-06-2025
  • Dividend Yield
  • ELEV N/A
  • AHT N/A
  • EPS Growth
  • ELEV N/A
  • AHT N/A
  • EPS
  • ELEV N/A
  • AHT N/A
  • Revenue
  • ELEV N/A
  • AHT $1,170,089,000.00
  • Revenue This Year
  • ELEV N/A
  • AHT N/A
  • Revenue Next Year
  • ELEV N/A
  • AHT N/A
  • P/E Ratio
  • ELEV N/A
  • AHT N/A
  • Revenue Growth
  • ELEV N/A
  • AHT N/A
  • 52 Week Low
  • ELEV $0.24
  • AHT $5.20
  • 52 Week High
  • ELEV $5.83
  • AHT $14.90
  • Technical
  • Relative Strength Index (RSI)
  • ELEV 23.65
  • AHT 39.85
  • Support Level
  • ELEV $0.24
  • AHT $7.18
  • Resistance Level
  • ELEV $0.55
  • AHT $7.55
  • Average True Range (ATR)
  • ELEV 0.04
  • AHT 0.47
  • MACD
  • ELEV -0.02
  • AHT -0.04
  • Stochastic Oscillator
  • ELEV 6.23
  • AHT 13.77

About ELEV Elevation Oncology Inc. Common stock

Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition.

About AHT Ashford Hospitality Trust Inc

Ashford Hospitality Trust Inc. is a real estate investment trust that invests in full-service upscale and upper-upscale hotel properties in the U.S. The company owns and operates its assets through its operating partnership, Ashford Hospitality Limited Partnership. All of its hotels are located across the U.S. and operate under the Marriott, Hilton, Hyatt, Crowne Plaza, and Sheraton brands. Ashford's sole segment is Direct Hotel Investments, through which it owns hotels by acquisition or development. Ashford also provides rest estate investment services, such as mezzanine financing, first mortgage financing, and sales-leaseback transactions. Its revenue streams include Room revenue, Food and beverage revenue, and Other revenue. Room revenue accounts for the majority of total revenue.

Share on Social Networks: